{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:29:39Z","timestamp":1793212179302,"version":"4.5.0"},"reference-count":241,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T00:00:00Z","timestamp":1705708800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019706","name":"QBRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019687","name":"Hamad Bin Khalifa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy: Oncology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.omton.2024.200768","type":"journal-article","created":{"date-parts":[[2024,1,26]],"date-time":"2024-01-26T08:35:14Z","timestamp":1706258114000},"page":"200768","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer"],"prefix":"10.1016","volume":"32","author":[{"given":"Adviti","family":"Naik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boucif","family":"Lattab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanan","family":"Qasem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4409-100X","authenticated-orcid":false,"given":"Julie","family":"Decock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2024.200768_bib1","article-title":"Multiple cancer\/testis antigens are preferentially expressed in hormone-receptor negative and high-grade breast cancers","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib2","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1111\/j.1349-7006.2009.01303.x","article-title":"Cancer\/testis (CT) antigens: potential targets for immunotherapy","volume":"100","author":"Caballero","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2024.200768_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.molonc.2011.02.001","article-title":"The biology of cancer testis antigens: putative function, regulation and therapeutic potential","volume":"5","author":"Fratta","year":"2011","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib4","first-page":"7002","article-title":"The expression, modulation and use of cancer-testis antigens as potential biomarkers for cancer immunotherapy","volume":"12","author":"Li","year":"2020","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.omton.2024.200768_bib5","article-title":"Oncogenic cancer\/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy","volume":"1876","author":"Yang","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.omton.2024.200768_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241914679","article-title":"Cancer\/Testis Antigens as Targets for RNA-Based Anticancer Therapy","volume":"24","author":"Shim","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200768_bib7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3892\/ijo.2023.5519","article-title":"Cancer testis antigen subfamilies: Attractive targets for therapeutic vaccine (Review)","volume":"62","author":"Ren","year":"2023","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.trecan.2018.08.005","article-title":"Emerging Contributions of Cancer\/Testis Antigens to Neoplastic Behaviors","volume":"4","author":"Gibbs","year":"2018","journal-title":"Trends Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/1471-2407-13-144","article-title":"Derepression of Cancer\/testis antigens in cancer is associated with distinct patterns of DNA hypomethylation","volume":"13","author":"Kim","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2017.03.029","article-title":"Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes","volume":"396","author":"Van Tongelen","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2024.200768_bib11","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4161\/epi.1.3.2988","article-title":"A potential role for epigenetic modulatory drugs in the enhancement of cancer\/germ-line antigen vaccine efficacy","volume":"1","author":"Karpf","year":"2006","journal-title":"Epigenetics"},{"key":"10.1016\/j.omton.2024.200768_bib12","doi-asserted-by":"crossref","first-page":"15772","DOI":"10.18632\/oncotarget.4694","article-title":"Oncogenic cancer\/testis antigens: prime candidates for immunotherapy","volume":"6","author":"Gjerstorff","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib13","article-title":"Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types","volume":"7","author":"Wang","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib14","doi-asserted-by":"crossref","first-page":"92966","DOI":"10.18632\/oncotarget.21715","article-title":"Genome-wide identification of cancer\/testis genes and their association with prognosis in a pan-cancer analysis","volume":"8","author":"da Silva","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1158\/2326-6066.CIR-13-0088","article-title":"Tumor subtype-specific cancer-testis antigens as potential biomarkers and immunotherapeutic targets for cancers","volume":"2","author":"Yao","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.omton.2024.200768_bib16","doi-asserted-by":"crossref","first-page":"20422","DOI":"10.1073\/pnas.0810777105","article-title":"Genome-wide analysis of cancer\/testis gene expression","volume":"105","author":"Hofmann","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2024.200768_bib17","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/1878-0261.13024","article-title":"Targeting of lactate dehydrogenase C dysregulates the cell cycle and sensitizes breast cancer cells to DNA damage response targeted therapy","volume":"16","author":"Naik","year":"2022","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112414","article-title":"Cancer\/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K\/Akt\/GSK-3beta-signaling pathway and the in lung adenocarcinoma","volume":"398","author":"Chen","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.omton.2024.200768_bib19","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317695968","article-title":"Expression of lactate dehydrogenase C correlates with poor prognosis in renal cell carcinoma","volume":"39","author":"Hua","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2024.200768_bib20","doi-asserted-by":"crossref","first-page":"19455","DOI":"10.18632\/aging.103879","article-title":"Cancer-testis antigen lactate dehydrogenase C4 in hepatocellular carcinoma: a promising biomarker for early diagnosis, efficacy evaluation and prognosis prediction","volume":"12","author":"Cui","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.omton.2024.200768_bib21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.18632\/oncotarget.950","article-title":"Expression of cancer\/testis antigens is correlated with improved survival in glioblastoma","volume":"4","author":"Freitas","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib22","article-title":"Cancer\/Testis Antigens as Biomarker and Target for the Diagnosis, Prognosis, and Therapy of Lung Cancer","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib23","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.arcmed.2019.12.002","article-title":"TSGA10 Over Expression Decreases Metastasic and Metabolic Activity by Inhibiting HIF-1 in Breast Cancer Cells","volume":"51","author":"Jahani","year":"2020","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.omton.2024.200768_bib24","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10585-011-9390-z","article-title":"RGS22, a novel cancer\/testis antigen, inhibits epithelial cell invasion and metastasis","volume":"28","author":"Hu","year":"2011","journal-title":"Clin. Exp. Metastasis"},{"key":"10.1016\/j.omton.2024.200768_bib25","doi-asserted-by":"crossref","first-page":"15505","DOI":"10.1074\/jbc.M310437200","article-title":"A cleaved form of MAGE-A4 binds to Miz-1 and induces apoptosis in human cells","volume":"279","author":"Sakurai","year":"2004","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omton.2024.200768_bib26","doi-asserted-by":"crossref","first-page":"44417","DOI":"10.18632\/oncotarget.10088","article-title":"SPANXA suppresses EMT by inhibiting c-JUN\/SNAI2 signaling in lung adenocarcinoma","volume":"7","author":"Hsiao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib27","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1038\/ncomms9840","article-title":"Comprehensive functional characterization of cancer-testis antigens defines obligate participation in multiple hallmarks of cancer","volume":"6","author":"Maxfield","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/imt-2017-0179","article-title":"Cancer testis antigens as immunogenic and oncogenic targets in breast cancer","volume":"10","author":"Mahmoud","year":"2018","journal-title":"Immunotherapy"},{"key":"10.1016\/j.omton.2024.200768_bib29","doi-asserted-by":"crossref","first-page":"10362","DOI":"10.1158\/0008-5472.CAN-10-1341","article-title":"Mage-A cancer\/testis antigens inhibit p53 function by blocking its interaction with chromatin","volume":"70","author":"Marcar","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/bjh.13762","article-title":"Cancer-testis antigen MAGEC2 promotes proliferation and resistance to apoptosis in Multiple Myeloma","volume":"171","author":"Lajmi","year":"2015","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.omton.2024.200768_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molonc.2014.09.001","article-title":"Ectopic expression of cancer\/testis antigen SSX2 induces DNA damage and promotes genomic instability","volume":"9","author":"Greve","year":"2015","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib32","doi-asserted-by":"crossref","first-page":"14475","DOI":"10.1074\/jbc.M109.084400","article-title":"The cancer\/testis antigen CAGE with oncogenic potential stimulates cell proliferation by up-regulating cyclins D1 and E in an AP-1- and E2F-dependent manner","volume":"285","author":"Por","year":"2010","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omton.2024.200768_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0095136","article-title":"Oncogenic functions of the cancer-testis antigen SSX on the proliferation, survival, and signaling pathways of cancer cells","volume":"9","author":"D\u2019Arcy","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib34","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/cdd.2011.173","article-title":"MageA2 restrains cellular senescence by targeting the function of PMLIV\/p53 axis at the PML-NBs","volume":"19","author":"Peche","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2024.200768_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10549-014-2915-9","article-title":"MAGEC2, an epithelial-mesenchymal transition inducer, is associated with breast cancer metastasis","volume":"145","author":"Yang","year":"2014","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.omton.2024.200768_bib36","doi-asserted-by":"crossref","first-page":"14708","DOI":"10.18632\/oncotarget.7408","article-title":"The cancer-testis antigens SPANX-A\/C\/D and CTAG2 promote breast cancer invasion","volume":"7","author":"Maine","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2021.103214","article-title":"Cancer testis antigens and genomic instability: More than immunology","volume":"108","author":"Jay","year":"2021","journal-title":"DNA Repair"},{"key":"10.1016\/j.omton.2024.200768_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17060890","article-title":"Ectopic Expression of Testis Germ Cell Proteins in Cancer and Its Potential Role in Genomic Instability","volume":"17","author":"Nielsen","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2024.200768_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.62852","article-title":"DNA damage-how and why we age?","volume":"10","author":"Yousefzadeh","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.omton.2024.200768_bib40","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/emboj.2008.15","article-title":"DNA-damage repair; the good, the bad, and the ugly","volume":"27","author":"Hakem","year":"2008","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2024.200768_bib41","article-title":"Brother of Regulator of Imprinted Sites (BORIS) suppresses apoptosis in colorectal cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib42","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1111\/cas.15732","article-title":"Boris knockout eliminates AOM\/DSS-induced in\u00a0situ colorectal cancer by suppressing DNA damage repair and inflammation","volume":"114","author":"Zuo","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2024.200768_bib43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3892\/ol.2020.12114","article-title":"Brother of regulator of imprinted sites inhibits cisplatin-induced DNA damage in non-small cell lung cancer","volume":"20","author":"Zhang","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omton.2024.200768_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cell.2018.08.065","article-title":"Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer","volume":"175","author":"Coscia","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200768_bib45","doi-asserted-by":"crossref","first-page":"4220","DOI":"10.1038\/s41598-021-83200-5","article-title":"YBX2 and cancer testis antigen 45 contribute to stemness, chemoresistance and a high degree of malignancy in human endometrial cancer","volume":"11","author":"Suzuki","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2443.2012.01600.x","article-title":"HORMAD1-dependent checkpoint\/surveillance mechanism eliminates asynaptic oocytes","volume":"17","author":"Kogo","year":"2012","journal-title":"Gene Cell."},{"key":"10.1016\/j.omton.2024.200768_bib47","doi-asserted-by":"crossref","first-page":"6196","DOI":"10.1158\/0008-5472.CAN-18-1377","article-title":"HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic Stress","volume":"78","author":"Nichols","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105348","article-title":"The cancer testes antigen, HORMAD1, limits genomic instability in cancer cells by protecting stalled replication forks","volume":"299","author":"Herrera","year":"2023","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omton.2024.200768_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1158\/2159-8290.CD-14-1092","article-title":"Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers","volume":"5","author":"Watkins","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omton.2024.200768_bib50","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1002\/1878-0261.13412","article-title":"HORMAD1 overexpression predicts response to anthracycline-cyclophosphamide and survival in triple-negative breast cancers","volume":"17","author":"El-Botty","year":"2023","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib51","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/s41419-020-2736-1","article-title":"Aberrantly expressed HORMAD1 disrupts nuclear localization of MCM8-MCM9 complex and compromises DNA mismatch repair in cancer cells","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2024.200768_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/or.2021.8146","article-title":"HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage tolerance Corrigendum in\/10.3892\/or.2021.8146","volume":"46","author":"Zong","year":"2021","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib53","doi-asserted-by":"crossref","first-page":"3969","DOI":"10.1038\/s41388-022-02369-9","article-title":"Functional screening reveals HORMAD1-driven gene dependencies associated with translesion synthesis and replication stress tolerance","volume":"41","author":"Tarantino","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200768_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2012.07.001","article-title":"Biological significance of HORMA domain containing protein 1 (HORMAD1) in epithelial ovarian carcinoma","volume":"330","author":"Shahzad","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2024.200768_bib55","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12105","article-title":"A neomorphic cancer cell-specific role of MAGE-A4 in trans-lesion synthesis","volume":"7","author":"Gao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib56","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3892\/ol_00000033","article-title":"Impact of MAGE-A antigens on taxane response in oral squamous cell carcinoma","volume":"1","author":"M\u00fcller-Richter","year":"2010","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omton.2024.200768_bib57","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1038\/ncomms3788","article-title":"MEIOB exhibits single-stranded DNA-binding and exonuclease activities and is essential for meiotic recombination","volume":"4","author":"Luo","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib58","doi-asserted-by":"crossref","first-page":"74","DOI":"10.20892\/j.issn.2095-3941.2020.0071","article-title":"The cancer-testis gene, MEIOB, sensitizes triple-negative breast cancer to PARP1 inhibitors by inducing homologous recombination deficiency","volume":"18","author":"Gu","year":"2021","journal-title":"Cancer Biol. Med."},{"key":"10.1016\/j.omton.2024.200768_bib59","doi-asserted-by":"crossref","first-page":"695","DOI":"10.4103\/1008-682X.181818","article-title":"Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer\/testis antigen, is a novel therapeutic target for prostate cancer","volume":"18","author":"Kulkarni","year":"2016","journal-title":"Asian J. Androl."},{"key":"10.1016\/j.omton.2024.200768_bib60","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.ajpath.2012.06.040","article-title":"PAGE4 positivity is associated with attenuated AR signaling and predicts patient survival in hormone-naive prostate cancer","volume":"181","author":"Sampson","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.omton.2024.200768_bib61","article-title":"A Panel of Cancer Testis Antigens and Clinical Risk Factors to Predict Metastasis in Colorectal Cancer","volume":"2014","author":"Molania","year":"2014","journal-title":"J.\u00a0Biomark."},{"key":"10.1016\/j.omton.2024.200768_bib62","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13046-019-1032-3","article-title":"PAGE4 promotes prostate cancer cells survive under oxidative stress through modulating MAPK\/JNK\/ERK pathway","volume":"38","author":"Lv","year":"2019","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib63","first-page":"39","article-title":"Prostate-associated gene 4 (PAGE4) protects cells against stress by elevating p21 and suppressing reactive oxygen species production","volume":"1","author":"Zeng","year":"2013","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.omton.2024.200768_bib64","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1080\/15384101.2020.1743902","article-title":"The ectopic expression of meiCT genes promotes meiomitosis and may facilitate carcinogenesis","volume":"19","author":"Gantchev","year":"2020","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2024.200768_bib65","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1101\/gr.231696.117","article-title":"Aberrant PRDM9 expression impacts the pan-cancer genomic landscape","volume":"28","author":"Houle","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2024.200768_bib66","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13059-018-1483-4","article-title":"Chromatin loop anchors are associated with genome instability in cancer and recombination hotspots in the germline","volume":"19","author":"Kaiser","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.omton.2024.200768_bib67","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gr.144188.112","article-title":"Rare allelic forms of PRDM9 associated with childhood leukemogenesis","volume":"23","author":"Hussin","year":"2013","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2024.200768_bib68","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/7050_2007_026","article-title":"Spo11 and the Formation of DNA Double-Strand Breaks in Meiosis","volume":"2","author":"Keeney","year":"2008","journal-title":"Genome Dyn. Stab."},{"key":"10.1016\/j.omton.2024.200768_bib69","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S1097-2765(00)00098-8","article-title":"Chromosome synapsis defects and sexually dimorphic meiotic progression in mice lacking Spo11","volume":"6","author":"Baudat","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2024.200768_bib70","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1097-2765(00)80404-9","article-title":"The murine SCP3 gene is required for synaptonemal complex assembly, chromosome synapsis, and male fertility","volume":"5","author":"Yuan","year":"2000","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2024.200768_bib71","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.1158\/0008-5472.CAN-17-2325","article-title":"Targeting Cyclin D-CDK4\/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3\u2013NANOG Axis","volume":"78","author":"Oh","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib72","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0098712","article-title":"Synaptonemal complex protein 3 is a prognostic marker in cervical cancer","volume":"9","author":"Cho","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/embor.2011.221","article-title":"Synaptonemal complex protein SYCP3 impairs mitotic recombination by interfering with BRCA2","volume":"13","author":"Hosoya","year":"2011","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omton.2024.200768_bib74","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3390\/biomedicines10030685","article-title":"Targeting CDK4\/6 for Anticancer Therapy","volume":"10","author":"Qi","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.omton.2024.200768_bib75","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/genes14040944","article-title":"SPAG9 Expression Predicts Good Prognosis in Patients with Clear-Cell Renal Cell Carcinoma: A Bioinformatics Analysis with Experimental Validation","volume":"14","author":"Qiao","year":"2023","journal-title":"Genes"},{"key":"10.1016\/j.omton.2024.200768_bib76","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.molimm.2017.05.006","article-title":"Scaffold protein JLP mediates TCR-initiated CD4+T cell activation and CD154 expression","volume":"87","author":"Yan","year":"2017","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omton.2024.200768_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081348","article-title":"Sperm associated antigen 9 plays an important role in bladder transitional cell carcinoma","volume":"8","author":"Kanojia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00428-015-1826-4","article-title":"Overexpression of SPAG9 in human gastric cancer is correlated with poor prognosis","volume":"467","author":"Miao","year":"2015","journal-title":"Virchows Arch."},{"key":"10.1016\/j.omton.2024.200768_bib79","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.1007\/s13277-014-2030-x","article-title":"Overexpression of SPAG9 correlates with poor prognosis and tumor progression in hepatocellular carcinoma","volume":"35","author":"Xie","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2024.200768_bib80","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1007\/s13277-014-1947-4","article-title":"SPAG9 is overexpressed in human prostate cancer and promotes cancer cell proliferation","volume":"35","author":"Li","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2024.200768_bib81","doi-asserted-by":"crossref","DOI":"10.1177\/1010428318773652","article-title":"Sperm associated antigen 9 (SPAG9) a promising therapeutic target of ovarian carcinoma","volume":"40","author":"Jagadish","year":"2018","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2024.200768_bib82","first-page":"2329","article-title":"SPAG9\/MKK3\/p38 axis is a novel therapeutic target for liver cancer","volume":"41","author":"Luo","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib83","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.biopha.2018.04.168","article-title":"Emerging role of sperm-associated antigen 9 in tumorigenesis","volume":"103","author":"Pan","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.omton.2024.200768_bib84","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/cdd.2010.70","article-title":"E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit","volume":"18","author":"Ingram","year":"2011","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2024.200768_bib85","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1074\/jbc.M606169200","article-title":"Human TFDP3, a novel DP protein, inhibits DNA binding and transactivation by E2F","volume":"282","author":"Qiao","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.omton.2024.200768_bib86","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.gene.2013.12.051","article-title":"TFDP3 was expressed in coordination with E2F1 to inhibit E2F1-mediated apoptosis in prostate cancer","volume":"537","author":"Ma","year":"2014","journal-title":"Gene"},{"key":"10.1016\/j.omton.2024.200768_bib87","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bbrc.2007.06.128","article-title":"TFDP3 inhibits E2F1-induced, p53-mediated apoptosis","volume":"361","author":"Tian","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182781","article-title":"Effects of cancer-testis antigen, TFDP3, on cell cycle regulation and its mechanism in L-02 and HepG2 cell lines in\u00a0vitro","volume":"12","author":"Jiao","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib89","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201745440","article-title":"Perturbing mitosis for anti-cancer therapy: is cell death the only answer?","volume":"19","author":"Haschka","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.omton.2024.200768_bib90","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1158\/1078-0432.CCR-20-4185","article-title":"A Phase I\u00a0Study of an MPS1 Inhibitor (BAY 1217389) in Combination with Paclitaxel Using a Novel Randomized Continual Reassessment Method for Dose Escalation","volume":"27","author":"Atrafi","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib91","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1158\/0008-5472.CAN-10-0840","article-title":"Tumor antigen acrosin binding protein normalizes mitotic spindle function to promote cancer cell proliferation","volume":"70","author":"Whitehurst","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib92","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1091\/mbc.e07-10-1051","article-title":"KNL1 and the CENP-H\/I\/K complex coordinately direct kinetochore assembly in vertebrates","volume":"19","author":"Cheeseman","year":"2008","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.omton.2024.200768_bib93","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.cub.2011.04.011","article-title":"KNL1\/Spc105 recruits PP1 to silence the spindle assembly checkpoint","volume":"21","author":"Rosenberg","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib94","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/cbf.3540","article-title":"CASC5 is a potential tumour driving gene in lung adenocarcinoma","volume":"38","author":"Cui","year":"2020","journal-title":"Cell Biochem. Funct."},{"key":"10.1016\/j.omton.2024.200768_bib95","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1134\/S0026893321010027","article-title":"CASC5 Gene Expression Changes Correlate with Targeted Mutations in Leukemia","volume":"55","author":"Bogdanov","year":"2021","journal-title":"Mol. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib96","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/emm.2007.90","article-title":"The centrosomal localization of KM-HN-1 (MGC33607) depends on the leucine zipper motif and the C-terminal coiled-coil domain","volume":"39","author":"Park","year":"2007","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2024.200768_bib97","doi-asserted-by":"crossref","first-page":"101","DOI":"10.12717\/DR.2020.24.2.101","article-title":"Ectopic Overexpression of Coiled-Coil Domain Containing 110 Delays G2\/M Entry in U2-OS Cells","volume":"24","author":"Lee","year":"2020","journal-title":"Dev. Reprod."},{"key":"10.1016\/j.omton.2024.200768_bib98","doi-asserted-by":"crossref","first-page":"4131","DOI":"10.1128\/MCB.00686-12","article-title":"Multiple cancer testis antigens function to support tumor cell mitotic fidelity","volume":"32","author":"Cappell","year":"2012","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib99","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s10529-011-0559-y","article-title":"Expression of the human cancer\/testis antigen NY-SAR-35 is activated by CpG island hypomethylation","volume":"33","author":"Park","year":"2011","journal-title":"Biotechnol. Lett."},{"key":"10.1016\/j.omton.2024.200768_bib100","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.bbrc.2017.01.105","article-title":"A cancer\/testis antigen, NY-SAR-35, induces EpCAM, CD44, and CD133, and activates ERK in HEK293 cells","volume":"484","author":"Song","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib101","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3892\/ijo.2015.3264","article-title":"Cancer\/testis antigen NY-SAR-35 enhances cell proliferation, migration, and invasion","volume":"48","author":"Song","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib102","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s11596-022-2586-4","article-title":"FMR1NB Involved in Glioma Tumorigenesis Is a Promising Target for Prognosis and Therapy","volume":"42","author":"Bi","year":"2022","journal-title":"Curr. Med. Sci."},{"key":"10.1016\/j.omton.2024.200768_bib103","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41388-021-02106-8","article-title":"Mitotic phosphorylation of tumor suppressor DAB2IP maintains spindle assembly checkpoint and chromosomal stability through activating PLK1-Mps1 signal pathway and stabilizing mitotic checkpoint complex","volume":"41","author":"Yu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200768_bib104","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0092-8674(01)00410-X","article-title":"Mps1 is a kinetochore-associated kinase essential for the vertebrate mitotic checkpoint","volume":"106","author":"Abrieu","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200768_bib105","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202106130","article-title":"Kinetochore-bound Mps1 regulates kinetochore-microtubule attachments via Ndc80 phosphorylation","volume":"220","author":"Sarangapani","year":"2021","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib106","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1158\/1535-7163.MCT-18-0864","article-title":"Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and Polyploidy","volume":"18","author":"Zheng","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.omton.2024.200768_bib107","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2119514119","article-title":"CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma","volume":"119","author":"Chan","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2024.200768_bib108","doi-asserted-by":"crossref","first-page":"10255","DOI":"10.1158\/0008-5472.CAN-10-2101","article-title":"Targeting the mitotic checkpoint for cancer therapy with NMS-P715, an inhibitor of MPS1 kinase","volume":"70","author":"Colombo","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.174899","article-title":"Multiple actions of NMS-P715, the monopolar spindle 1 (MPS1) mitotic checkpoint inhibitor in liver fluke-associated cholangiocarcinoma cells","volume":"922","author":"Waenphimai","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.omton.2024.200768_bib110","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.180109","article-title":"Leader of the SAC: molecular mechanisms of Mps1\/TTK regulation in mitosis","volume":"8","author":"Pachis","year":"2018","journal-title":"Open Biol."},{"key":"10.1016\/j.omton.2024.200768_bib111","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1158\/1535-7163.MCT-15-0500","article-title":"Novel Mps1 Kinase Inhibitors with Potent Antitumor Activity","volume":"15","author":"Wengner","year":"2016","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.omton.2024.200768_bib112","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1083\/jcb.201308172","article-title":"Mps1 phosphorylation of condensin II controls chromosome condensation at the onset of mitosis","volume":"205","author":"Kagami","year":"2014","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib113","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cell.2007.11.046","article-title":"Mps1 phosphorylates Borealin to control Aurora B activity and chromosome alignment","volume":"132","author":"Jelluma","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200768_bib114","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/emboj\/21.7.1723","article-title":"Human Mps1 kinase is required for the spindle assembly checkpoint but not for centrosome duplication","volume":"21","author":"Stucke","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.omton.2024.200768_bib115","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1158\/1535-7163.MCT-11-0453","article-title":"Characterization of the cellular and antitumor effects of MPI-0479605, a small-molecule inhibitor of the mitotic kinase Mps1","volume":"10","author":"Tardif","year":"2011","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.omton.2024.200768_bib116","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.ejca.2022.04.001","article-title":"First-in-man, first-in-class phase I study with the monopolar spindle 1 kinase inhibitor S81694 administered intravenously in adult patients with advanced, metastatic solid tumours","volume":"169","author":"Sch\u00f6ffski","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib117","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1158\/1535-7163.MCT-18-1203","article-title":"High Proliferation Rate and a Compromised Spindle Assembly Checkpoint Confers Sensitivity to the MPS1 Inhibitor BOS172722 in Triple-Negative Breast Cancers","volume":"18","author":"Anderhub","year":"2019","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.omton.2024.200768_bib118","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3892\/ol.2021.13058","article-title":"Targeting Mps1 in combination with paclitaxel inhibits osteosarcoma progression by modulating spindle assembly checkpoint and Akt\/mTOR signaling","volume":"22","author":"Lu","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omton.2024.200768_bib119","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/s41419-022-05312-8","article-title":"Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer","volume":"13","author":"Sarwar","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2024.200768_bib120","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/s41416-018-0081-2","article-title":"Mps1 inhibitors synergise with low doses of taxanes in promoting tumour cell death by enhancement of errors in cell division","volume":"118","author":"Maia","year":"2018","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib121","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1093\/annonc\/mdv293","article-title":"Inhibition of the spindle assembly checkpoint kinase TTK enhances the efficacy of docetaxel in a triple-negative breast cancer model","volume":"26","author":"Maia","year":"2015","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib122","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/cdd.2013.105","article-title":"Characterization of novel MPS1 inhibitors with preclinical anticancer activity","volume":"20","author":"Jema\u00e0","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2024.200768_bib123","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molonc.2013.12.018","article-title":"TP53 mutation-correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53-mutated breast cancers","volume":"8","author":"Gy\u0151rffy","year":"2014","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib124","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/nar\/gkv1173","article-title":"Requirement for human Mps1\/TTK in oxidative DNA damage repair and cell survival through MDM2 phosphorylation","volume":"44","author":"Yu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2024.200768_bib125","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1128\/MCB.01837-08","article-title":"TTK\/hMps1 mediates the p53-dependent postmitotic checkpoint by phosphorylating p53 at Thr18","volume":"29","author":"Huang","year":"2009","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib126","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1158\/1541-7786.MCR-14-0462-T","article-title":"Targeting MPS1 Enhances Radiosensitization of Human Glioblastoma by Modulating DNA Repair Proteins","volume":"13","author":"Maachani","year":"2015","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib127","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ydbio.2009.03.022","article-title":"Inactivation of Nxf2 causes defects in male meiosis and age-dependent depletion of spermatogonia","volume":"330","author":"Pan","year":"2009","journal-title":"Dev. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib128","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1083\/jcb.200709057","article-title":"Mouse TEX15 is essential for DNA double-strand break repair and chromosomal synapsis during male meiosis","volume":"180","author":"Yang","year":"2008","journal-title":"J.\u00a0Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib129","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1093\/hmg\/ddv290","article-title":"Exome sequencing reveals a nonsense mutation in TEX15 causing spermatogenic failure in a Turkish family","volume":"24","author":"Okutman","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omton.2024.200768_bib130","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/pros.23387","article-title":"TEX15: A DNA repair gene associated with prostate cancer risk in Han Chinese","volume":"77","author":"Lin","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.omton.2024.200768_bib131","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41598-017-00766-9","article-title":"Case-control analysis of truncating mutations in DNA damage response genes connects TEX15 and FANCD2 with hereditary breast cancer susceptibility","volume":"7","author":"Mantere","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib132","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/mc.22812","article-title":"Pseudopod-associated protein KIF20B promotes Gli1-induced epithelial-mesenchymal transition modulated by pseudopodial actin dynamic in human colorectal cancer","volume":"57","author":"Lin","year":"2018","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.omton.2024.200768_bib133","first-page":"2202","article-title":"Kinesin family member 20B regulates tongue cancer progression by promoting cell proliferation","volume":"19","author":"Li","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib134","doi-asserted-by":"crossref","first-page":"16517","DOI":"10.1002\/jcp.28322","article-title":"KIF20B promotes the progression of clear cell renal cell carcinoma by stimulating cell proliferation","volume":"234","author":"Li","year":"2019","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omton.2024.200768_bib135","article-title":"KIF20B Promotes Cell Proliferation and May Be a Potential Therapeutic Target in Pancreatic Cancer","volume":"2021","author":"Chen","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib136","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/0008-5472.CAN-06-3748","article-title":"Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer","volume":"67","author":"Kanehira","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib137","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1158\/0008-5472.CAN-14-1279","article-title":"MPHOSPH1: a potential therapeutic target for hepatocellular carcinoma","volume":"74","author":"Liu","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib138","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1111\/cas.13794","article-title":"Inhibition of kinesin family member 20B sensitizes hepatocellular carcinoma cell to microtubule-targeting agents by blocking cytokinesis","volume":"109","author":"Liu","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2024.200768_bib139","doi-asserted-by":"crossref","first-page":"8491","DOI":"10.1158\/0008-5472.CAN-09-2131","article-title":"ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors","volume":"69","author":"Cir\u00f3","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib140","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.bbrc.2022.01.036","article-title":"ATAD2 drives colorectal cancer progression by regulating TRIM25 expression via a positive feedback loop with E2F transcriptional factors","volume":"594","author":"Tong","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib141","doi-asserted-by":"crossref","first-page":"70323","DOI":"10.18632\/oncotarget.11855","article-title":"ATAD2 is an epigenetic reader of newly synthesized histone marks during DNA replication","volume":"7","author":"Koo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib142","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1128\/MCB.00484-10","article-title":"Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark","volume":"30","author":"Revenko","year":"2010","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib143","first-page":"318","article-title":"Targeting bromodomain protein ANCCA\/ATAD2 enhances the efficacy of DNA-damaging chemotherapy agents and radiation","volume":"43","author":"Duan","year":"2020","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib144","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbrc.2022.10.021","article-title":"ATAD2 suppression enhances the combinatorial effect of gemcitabine and radiation in pancreatic cancer cells","volume":"635","author":"Dutta","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib145","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1128\/MCB.24.7.2767-2778.2004","article-title":"The yeast split-ubiquitin membrane protein two-hybrid screen identifies BAP31 as a regulator of the turnover of endoplasmic reticulum-associated protein tyrosine phosphatase-like B","volume":"24","author":"Wang","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib146","doi-asserted-by":"crossref","first-page":"6592","DOI":"10.1128\/MCB.24.15.6592-6607.2004","article-title":"Association of active caspase 8 with the mitochondrial membrane during apoptosis: potential roles in cleaving BAP31 and caspase 3 and mediating mitochondrion-endoplasmic reticulum cross talk in etoposide-induced cell death","volume":"24","author":"Chandra","year":"2004","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.omton.2024.200768_bib147","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.bbamcr.2011.11.018","article-title":"The ER-mitochondria interface: the social network of cell death","volume":"1823","author":"Grimm","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.omton.2024.200768_bib148","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11658-023-00434-z","article-title":"p20BAP31 induces cell apoptosis via both AIF caspase-independent and the ROS\/JNK mitochondrial pathway in colorectal cancer","volume":"28","author":"Jiang","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.omton.2024.200768_bib149","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/ijc.31930","article-title":"A BAP31 intrabody induces gastric cancer cell death by inhibiting p27(kip1) proteasome degradation","volume":"144","author":"Chen","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.bbrc.2018.11.017","article-title":"Inhibition of BAP31 expression inhibits cervical cancer progression by suppressing metastasis and inducing intrinsic and extrinsic apoptosis","volume":"508","author":"Wang","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib151","doi-asserted-by":"crossref","first-page":"858","DOI":"10.3892\/etm.2021.10290","article-title":"B-cell receptor-associated protein 31 promotes migration and invasion in ovarian cancer cells","volume":"22","author":"Liang","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.omton.2024.200768_bib152","article-title":"B-Cell Receptor-Associated Protein 31 Promotes Metastasis via AKT\/beta-Catenin\/Snail Pathway in Hepatocellular Carcinoma","volume":"8","author":"Liu","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omton.2024.200768_bib153","article-title":"BAP31 Regulates Wnt Signaling to Modulate Cell Migration in Lung Cancer","volume":"12","author":"Li","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib154","article-title":"BAP31 Promotes Proliferation, Invasion, and Metastasis of Liver Cancer Cells via Activating PI3K\/AKT Pathway","volume":"2022","author":"Sun","year":"2022","journal-title":"J.\u00a0Healthc. Eng."},{"key":"10.1016\/j.omton.2024.200768_bib155","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.607906","article-title":"BAP31 Promotes Tumor Cell Proliferation by Stabilizing SERPINE2 in Hepatocellular Carcinoma","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib156","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/cam4.3601","article-title":"MiR-362 suppresses cervical cancer progression via directly targeting BAP31 and activating TGFbeta\/Smad pathway","volume":"10","author":"Yang","year":"2021","journal-title":"Cancer Med."},{"key":"10.1016\/j.omton.2024.200768_bib157","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.4161\/cc.8.22.10047","article-title":"Cep55 stabilization is required for normal execution of cytokinesis","volume":"8","author":"van der Horst","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.omton.2024.200768_bib158","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s42003-020-01304-6","article-title":"Cep55 overexpression promotes genomic instability and tumorigenesis in mice","volume":"3","author":"Sinha","year":"2020","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib159","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/onc.2015.128","article-title":"Beyond cytokinesis: the emerging roles of CEP55 in tumorigenesis","volume":"35","author":"Jeffery","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200768_bib160","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.201708566","article-title":"CEP55 is a determinant of cell fate during perturbed mitosis in breast cancer","volume":"10","author":"Kalimutho","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.omton.2024.200768_bib161","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s11010-022-04607-w","article-title":"CEP55 predicts the poor prognosis and promotes tumorigenesis in endometrial cancer by regulating the Foxo1 signaling","volume":"478","author":"Zhang","year":"2023","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.omton.2024.200768_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.936767","article-title":"Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer","volume":"12","author":"Wu","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib163","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1095\/biolreprod.113.108530","article-title":"Glycolysis and mitochondrial respiration in mouse LDHC-null sperm","volume":"88","author":"Odet","year":"2013","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.omton.2024.200768_bib164","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1095\/biolreprod.111.091546","article-title":"Lactate dehydrogenase C and energy metabolism in mouse sperm","volume":"85","author":"Odet","year":"2011","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.omton.2024.200768_bib165","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1115620","article-title":"Commentary: Cancer-testis antigen lactate dehydrogenase C4 as a novel biomarker of male infertility and cancer","volume":"13","author":"Naik","year":"2023","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib166","first-page":"6750","article-title":"Multiple splice variants of lactate dehydrogenase C selectively expressed in human cancer","volume":"62","author":"Koslowski","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib167","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1016\/j.apsb.2021.12.002","article-title":"Identification of human LDHC4 as a potential target for anticancer drug discovery","volume":"12","author":"Tan","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.omton.2024.200768_bib168","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00262-020-02480-4","article-title":"Identification of two HLA-A\u22170201 immunogenic epitopes of lactate dehydrogenase C (LDHC): potential novel targets for cancer immunotherapy","volume":"69","author":"Thomas","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.omton.2024.200768_bib169","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/jid.2012.355","article-title":"MAGE-C2 promotes growth and tumorigenicity of melanoma cells, phosphorylation of KAP1, and DNA damage repair","volume":"133","author":"Bhatia","year":"2013","journal-title":"J.\u00a0Invest. Dermatol."},{"key":"10.1016\/j.omton.2024.200768_bib170","article-title":"The Dual Roles of MAGE-C2 in p53\u00a0Ubiquitination and Cell Proliferation Through E3 Ligases MDM2 and\u00a0TRIM28","volume":"10","author":"Liu","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib171","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.molcel.2010.09.006","article-title":"aMAGEing new players enter the RING to promote ubiquitylation","volume":"39","author":"Espantman","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omton.2024.200768_bib172","doi-asserted-by":"crossref","first-page":"42028","DOI":"10.18632\/oncotarget.5973","article-title":"Cancer-testis antigen MAGE-C2 binds Rbx1 and inhibits ubiquitin ligase-mediated turnover of cyclin E","volume":"6","author":"Hao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.omton.2024.200768_bib173","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021366","article-title":"MAGE-C2\/CT10 protein expression is an independent predictor of recurrence in prostate cancer","volume":"6","author":"von Boehmer","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.omton.2024.200768_bib174","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.devcel.2006.11.002","article-title":"Priming of centromere for CENP-A recruitment by human hMis18alpha, hMis18beta, and M18BP1","volume":"12","author":"Fujita","year":"2007","journal-title":"Dev. Cell"},{"key":"10.1016\/j.omton.2024.200768_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.805552","article-title":"OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates","volume":"13","author":"Gong","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2024.200768_bib176","doi-asserted-by":"crossref","first-page":"117","DOI":"10.21037\/atm-22-6640","article-title":"The mitosis-related gene OIP5 is a potential biomarker in pan-cancer","volume":"11","author":"Pan","year":"2023","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.omton.2024.200768_bib177","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5317","article-title":"Characterization of Opa interacting protein 5 as a new biomarker and therapeutic target for oral cancer","volume":"60","author":"Zhu","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib178","first-page":"2075","article-title":"Overexpression of Opa interacting protein 5 increases the progression of liver cancer via BMPR2\/JUN\/CHEK1\/RAC1 dysregulation","volume":"41","author":"Li","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib179","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1007\/s00432-017-2485-4","article-title":"Opa interacting protein 5 acts as an oncogene in bladder cancer","volume":"143","author":"He","year":"2017","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib180","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13092232","article-title":"PBK\/TOPK: An Effective Drug Target with Diverse Therapeutic Potential","volume":"13","author":"Huang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200768_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2021.755911","article-title":"An Integrative Pan-Cancer Analysis of PBK in Human Tumors","volume":"8","author":"Wen","year":"2021","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omton.2024.200768_bib182","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/cells10020371","article-title":"PBK\/TOPK: A Therapeutic Target Worthy of Attention","volume":"10","author":"Han","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.omton.2024.200768_bib183","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.3892\/or.2015.4308","article-title":"PBK\/TOPK mediates promyelocyte proliferation via Nrf2-regulated cell cycle progression and apoptosis","volume":"34","author":"Liu","year":"2015","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib184","doi-asserted-by":"crossref","first-page":"5464","DOI":"10.1038\/onc.2010.275","article-title":"PBK\/TOPK interacts with the DBD domain of tumor suppressor p53 and modulates expression of transcriptional targets including p21","volume":"29","author":"Hu","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.omton.2024.200768_bib185","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/s41418-020-00655-1","article-title":"Targeting TOPK sensitises tumour cells to radiation-induced damage by enhancing replication stress","volume":"28","author":"Herbert","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.omton.2024.200768_bib186","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.tranon.2019.09.011","article-title":"PDZ-Binding Kinase-Dependent Transcriptional Regulation of CCNB2 Promotes Tumorigenesis and Radio-Resistance in Glioblastoma","volume":"13","author":"Mao","year":"2020","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib187","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s12276-022-00809-w","article-title":"PBK drives PARP inhibitor resistance through the TRIM37\/NF\u03baB axis in ovarian cancer","volume":"54","author":"Ma","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.omton.2024.200768_bib188","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41419-019-1415-6","article-title":"PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma","volume":"10","author":"Ma","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2024.200768_bib189","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/jcp.30134","article-title":"PBK promotes aggressive phenotypes of cervical cancer through ERK\/c-Myc signaling pathway","volume":"236","author":"Ma","year":"2021","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.omton.2024.200768_bib190","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/2211-5463.12855","article-title":"PBK attenuates paclitaxel-induced autophagic cell death by suppressing p53 in H460 non-small-cell lung cancer cells","volume":"10","author":"Park","year":"2020","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omton.2024.200768_bib191","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1530\/ERC-19-0262","article-title":"Targeting PDZ-binding kinase is anti-tumorigenic in novel preclinical models of ACC","volume":"26","author":"Kar","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib192","first-page":"801","article-title":"Mitotic kinase PBK\/TOPK as a therapeutic target for adult T-cell leukemia\/lymphoma","volume":"53","author":"Ishikawa","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib193","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/cancers14092078","article-title":"Genotyping of Circulating Free DNA Enables Monitoring of Tumor Dynamics in Synovial Sarcomas","volume":"14","author":"Eisenhardt","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200768_bib194","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/gcc.22999","article-title":"Undifferentiated sarcoma of bone with a round to epithelioid cell phenotype harboring a novel EWSR1-SSX2 fusion identified by RNA-based next-generation sequencing","volume":"61","author":"Cordier","year":"2022","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib195","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/his.14190","article-title":"When used together SS18-SSX fusion-specific and SSX C-terminus immunohistochemistry are highly specific and sensitive for the diagnosis of synovial sarcoma and can replace FISH or molecular testing in most cases","volume":"77","author":"Zaborowski","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.omton.2024.200768_bib196","doi-asserted-by":"crossref","first-page":"11433","DOI":"10.1093\/nar\/gku852","article-title":"SSX2 is a novel DNA-binding protein that antagonizes polycomb group body formation and gene repression","volume":"42","author":"Gjerstorff","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2024.200768_bib197","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1093\/nar\/gkz396","article-title":"Remodeling and destabilization of chromosome 1 pericentromeric heterochromatin by SSX proteins","volume":"47","author":"Traynor","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2024.200768_bib198","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/s41419-019-2068-1","article-title":"A functional genetic screen identifies the Mediator complex as essential for SSX2-induced senescence","volume":"10","author":"Br\u00fcckmann","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.omton.2024.200768_bib199","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/s42003-021-02887-4","article-title":"Centrosome dysfunction associated with somatic expression of the synaptonemal complex protein TEX12","volume":"4","author":"Sandhu","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.omton.2024.200768_bib200","article-title":"Identify a DNA Damage Repair Gene Signature for Predicting Prognosis and Immunotherapy Response in Cervical Squamous Cell Carcinoma","volume":"2022","author":"Zhou","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib201","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1126\/science.1840703","article-title":"A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma","volume":"254","author":"van der Bruggen","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.omton.2024.200768_bib202","doi-asserted-by":"crossref","first-page":"11810","DOI":"10.1073\/pnas.92.25.11810","article-title":"Human neoplasms elicit multiple specific immune responses in the autologous host","volume":"92","author":"Sahin","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omton.2024.200768_bib203","doi-asserted-by":"crossref","first-page":"947","DOI":"10.3389\/fimmu.2018.00947","article-title":"NY-ESO-1 Based Immunotherapy of Cancer: Current Perspectives","volume":"9","author":"Thomas","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2024.200768_bib204","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cancers11070984","article-title":"Cancer Testis Antigens and Immunotherapy: Where Do We Stand in the Targeting of PRAME?","volume":"11","author":"Al-Khadairi","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2024.200768_bib205","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/j.1349-7006.2009.01200.x","article-title":"Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer","volume":"100","author":"Kono","year":"2009","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2024.200768_bib206","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1111\/j.1349-7006.2010.01732.x","article-title":"Vaccination with peptides derived from cancer-testis antigens in combination with CpG-7909 elicits strong specific CD8+ T\u00a0cell response in patients with metastatic esophageal squamous cell carcinoma","volume":"101","author":"Iwahashi","year":"2010","journal-title":"Cancer Sci."},{"key":"10.1016\/j.omton.2024.200768_bib207","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1479-5876-11-97","article-title":"Multiple therapeutic peptide vaccines consisting of combined novel cancer testis antigens and anti-angiogenic peptides for patients with non-small cell lung cancer","volume":"11","author":"Suzuki","year":"2013","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omton.2024.200768_bib208","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1479-5876-12-84","article-title":"Phase I clinical study of multiple epitope peptide vaccine combined with chemoradiation therapy in esophageal cancer patients","volume":"12","author":"Iinuma","year":"2014","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.omton.2024.200768_bib209","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1200\/JCO.20.02224","article-title":"T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects","volume":"39","author":"Vasileiou","year":"2021","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib210","article-title":"TriMix and tumor antigen mRNA electroporated dendritic cell vaccination plus ipilimumab: link between T-cell activation and clinical responses in advanced melanoma","volume":"8","author":"De Keersmaecker","year":"2020","journal-title":"J.\u00a0Immunother. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib211","first-page":"332","article-title":"Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T\u00a0cell therapy: a case report","volume":"33","author":"He","year":"2023","journal-title":"Melanoma Res."},{"key":"10.1016\/j.omton.2024.200768_bib212","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s41591-022-02128-z","article-title":"Autologous T\u00a0cell therapy for MAGE-A4(+) solid cancers in HLA-A\u221702(+) patients: a phase 1 trial","volume":"29","author":"Hong","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.omton.2024.200768_bib213","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1158\/1078-0432.CCR-14-1559","article-title":"Adoptive Transfer of MAGE-A4 T-cell Receptor Gene-Transduced Lymphocytes in Patients with Recurrent Esophageal Cancer","volume":"21","author":"Kageyama","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib214","doi-asserted-by":"crossref","first-page":"11504","DOI":"10.1200\/JCO.2021.39.15_suppl.11504","article-title":"SPEARHEAD-1: A phase 2 trial of afamitresgene autoleucel (Formerly ADP-A2M4) in patients with advanced synovial sarcoma or myxoid\/round cell liposarcoma","volume":"39","author":"D\u2019Angelo","year":"2021","journal-title":"J.\u00a0Clin. Orthod."},{"key":"10.1016\/j.omton.2024.200768_bib215","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/CJI.0000000000000456","article-title":"Enhancing Efficacy of TCR-engineered CD4\u00a0+ T Cells Via Coexpression of CD8\u03b1","volume":"46","author":"Anderson","year":"2023","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.omton.2024.200768_bib216","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/cells12060926","article-title":"Biology of Cancer-Testis Antigens and Their Therapeutic Implications in Cancer","volume":"12","author":"Nin","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omton.2024.200768_bib217","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.bbrc.2021.01.089","article-title":"TTK inhibitor promotes radiosensitivity of liver cancer cells through p21","volume":"550","author":"Zhang","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib218","doi-asserted-by":"crossref","first-page":"10376","DOI":"10.1111\/jcmm.16967","article-title":"Cancer testis antigen PRAME: An anti-cancer target with immunomodulatory potential","volume":"25","author":"Naik","year":"2021","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.omton.2024.200768_bib219","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.3390\/cells12202457","article-title":"CEP55 as a Promising Immune Intervention Marker to Regulate Tumor Progression: A Pan-Cancer Analysis with Experimental Verification","volume":"12","author":"Wang","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.omton.2024.200768_bib220","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2023.1198557","article-title":"Cancer-testis antigen CEP55 serves as a prognostic biomarker and is correlated with immune infiltration and immunotherapy efficacy in pan-cancer","volume":"10","author":"Xie","year":"2023","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.omton.2024.200768_bib221","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.3390\/diagnostics13091613","article-title":"A Comprehensive Pan-Cancer Analysis Identifies CEP55 as a Potential Oncogene and Novel Therapeutic Target","volume":"13","author":"Zaki","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/j.omton.2024.200768_bib222","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47781-7","article-title":"PBK correlates with prognosis, immune escape and drug response in LUAD","volume":"13","author":"Ma","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omton.2024.200768_bib223","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12957-021-02479-w","article-title":"High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma","volume":"20","author":"Mu","year":"2022","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib224","article-title":"PDZ Binding Kinase\/T-LAK Cell-Derived Protein Kinase Plays an Oncogenic Role and Promotes Immune Escape in Human Tumors","volume":"2021","author":"Feng","year":"2021","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib225","doi-asserted-by":"crossref","first-page":"899","DOI":"10.7150\/jca.50443","article-title":"Six Novel Biomarkers for Diagnosis and Prognosis of Esophageal squamous cell carcinoma: validated by scRNA-seq and qPCR","volume":"12","author":"Zheng","year":"2021","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib226","article-title":"TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1","volume":"26","author":"Li","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.omton.2024.200768_bib227","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.cell.2018.03.026","article-title":"Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade","volume":"173","author":"Shukla","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.omton.2024.200768_bib228","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.1007\/s00432-022-04514-z","article-title":"Combinational expression of tumor testis antigens NY-ESO-1, MAGE-A3, and MAGE-A4 predicts response to immunotherapy in mucosal melanoma patients","volume":"149","author":"Freiberger","year":"2023","journal-title":"J.\u00a0Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.omton.2024.200768_bib229","first-page":"191","article-title":"CEP55 Inhibitor: Extensive Computational Approach Defining a New Target of Cell Cycle Machinery Agent","volume":"12","author":"Lestari","year":"2022","journal-title":"Adv. Pharmaceut. Bull."},{"key":"10.1016\/j.omton.2024.200768_bib230","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1021\/acs.jnatprod.5b00962","article-title":"Depsidones from Lichens as Natural Product Inhibitors of M-Phase Phosphoprotein 1, a Human Kinesin Required for Cytokinesis","volume":"79","author":"Talapatra","year":"2016","journal-title":"J.\u00a0Nat. Prod."},{"key":"10.1016\/j.omton.2024.200768_bib231","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/s41467-019-13652-x","article-title":"Discovery of a chemical probe for PRDM9","volume":"10","author":"Allali-Hassani","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omton.2024.200768_bib232","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2018.12.016","article-title":"Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasis","volume":"445","author":"Gao","year":"2019","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omton.2024.200768_bib233","doi-asserted-by":"crossref","first-page":"259ra145","DOI":"10.1126\/scitranslmed.3010277","article-title":"TOPK inhibitor induces complete tumor regression in xenograft models of human cancer through inhibition of cytokinesis","volume":"6","author":"Matsuo","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omton.2024.200768_bib234","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/cam4.2695","article-title":"Potent anti-myeloma activity of the TOPK inhibitor OTS514 in pre-clinical models","volume":"9","author":"Stefka","year":"2020","journal-title":"Cancer Med."},{"key":"10.1016\/j.omton.2024.200768_bib235","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3324\/haematol.2018.208306","article-title":"Kinome expression profiling to target new therapeutic avenues in multiple myeloma","volume":"105","author":"de Boussac","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.omton.2024.200768_bib236","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12943-022-01621-w","article-title":"BTApep-TAT peptide inhibits ADP-ribosylation of BORIS to induce DNA damage in cancer","volume":"21","author":"Zhang","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib237","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1158\/1538-7445.AM2019-1418","article-title":"Abstract 1418: Brother of regulator of imprinted sites (BORIS) inhibits cisplatin induced DNA damage in non-small-cell lung cancer","volume":"79","author":"Song","year":"2019","journal-title":"Cancer Res."},{"key":"10.1016\/j.omton.2024.200768_bib238","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.7150\/jca.27381","article-title":"OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells","volume":"9","author":"Wang","year":"2018","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.omton.2024.200768_bib239","doi-asserted-by":"crossref","DOI":"10.1177\/1010428317733985","article-title":"Opa-interacting protein 5 modulates docetaxel-induced cell death via regulation of mitophagy in gastric cancer","volume":"39","author":"Kim","year":"2017","journal-title":"Tumour Biol."},{"key":"10.1016\/j.omton.2024.200768_bib240","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202102494","article-title":"Reduction-Sensitive Fluorinated-Pt(IV) Universal Transfection Nanoplatform Facilitating CT45-Targeted CRISPR\/dCas9 Activation for Synergistic and Individualized Treatment of Ovarian Cancer","volume":"17","author":"Lu","year":"2021","journal-title":"Small"},{"key":"10.1016\/j.omton.2024.200768_bib241","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/cam4.1924","article-title":"MicroRNA-372 enhances radiosensitivity while inhibiting cell invasion and metastasis in nasopharyngeal carcinoma through activating the PBK-dependent p53 signaling pathway","volume":"8","author":"Wang","year":"2019","journal-title":"Cancer Med."}],"container-title":["Molecular Therapy: Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329924000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T18:07:29Z","timestamp":1726855649000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329924000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":241,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2950329924000109"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2024.200768","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer testis antigens: Emerging therapeutic targets leveraging genomic instability in cancer","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy: Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2024.200768","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"200768"}}